Office Assessed Blood Pressure and Ambulatory Blood Pressure Monitoring in Chronic Kidney Disease Patients Versus Kidney Transplant Recipients

Open access


How reliable is office assessed blood pressure (BP) in chronic kidney disease (CKD) patients and kidney transplant (KTx) recipients is yet to be determined, although the diagnosis of arterial hypertension has been based on these measurements. The aim of this study was to investigate the potential differences between office assessed BP and ambulatory blood pressure monitoring (ABPM) in CKD patients and KTx recipients. We conducted a prospective study which enrolled 45 patients. Morning and evening seated office BPs were assessed using a sphygmomanometer at 5 consecutive outpatient visits. A mean systolic BP (SBP) and diastolic BP (DBP) was calculated. Ambulatory blood pressure was measured over 24 hours using a Meditech ABPM-05 device. Office SBP was statistically significant higher in CKD patients than KTx recipients both in the morning and evening (p=0.0433 and p=0.0066 respectively). ABPM showed higher night-time SBPs (p=0.0445) and higher overall, day-time and night-time DBPs in KTX recipients (p=0.0001, p=0.0006, p<0.0001 respectively). In CKD patients, office SBPs and DBPs are significantly higher than overall SBPs and DBPs as assessed by 24hr ABPM. Office BP monitoring as assessed by clinician is acceptable but tends to overestimate BP in both CKD and KTx study groups.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Opelz G Wujciak T Ritz E - Association of chronic kidney graft failure with recipient blood pressure. Kidney International 1998; 53:217–222.

  • 2. Mange KC Cizman B Joffe M Feldman HI - Arterial hypertension and renal allograft survival. Journal of the American Medical Association 2000;283:633–638.

  • 3. Stenehjem AE Gudmundsdottir H Os I - Office blood pressure measurements overestimate blood pressure control in renal transplant patients. Blood Pressure Monitoring 2006;11:125–133.

  • 4. Iimuro S Imai E Watanabe T et al - Chronic Kidney Disease Japan Cohort Study Group. Clinical correlates of ambulatory BP monitoring among patients with CKD 2013;8:721-730.

  • 5. Czyżewski Ł Wyzgał J Kołek A - Evaluation of selected risk factors of cardiovascular diseases among patients after kidney transplantation with particular focus on the role of 24-hour automatic blood pressure measurement in the diagnosis of hypertension: an introductory report. Ann Transplant 2014;19:188-198.

  • 6. Sarafidis PA Rumjon A Macdougall IC - Ambulatory blood pressure monitoring:An Invaluable Tool Comes of Age for Patients with Chronic Kidney Disease? Am J Nephrol 2012;35:238–241.

  • 7. Wang J Guo R Liu S et al - Molecular mechanisms of FK506-induced hypertension in solid organ transplantation patients 2014;127:3645-3650.

  • 8. Xue W Zhang Q Xu Y Wang W Zhang X Hu X - Effects of tacrolimus and cyclosporine treatment on metabolic syndrome and cardiovascular risk factors after renal transplantation: a meta-analysis. Chin Med J (Engl) 2014;127:2376-2381.

  • 9. Ponticelli C Cucchiari D Graziani G. - Hypertension in kidney transplant recipients. Transpl Int 2011;24:523-533.

  • 10. Parati G Stergiou G O’Brien E et al - European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 2014;32:1359-1366.

  • 11. Paoletti E Gherzi M Amidone M Massarino F Cannella G - Association of arterial hypertension with renal target organ damage in kidney transplant recipients: the predictive role of ambulatory blood pressure monitoring. Transplantation 2009;87:1864–1869.

  • 12. SarafidisPA Sharpe CC Wood E et al - Prevalence patterns of treatment and control ofhypertensionin predialysis patients with chronic kidney disease. Nephron Clin Pract 2012;120:c147-155.

  • 13. Farag YM Mittal BV Keithi-Reddy SR et al - Burden and predictors of hypertension in India: results of SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrol 2014;15:42.

  • 14. Alani H Tamimi A Tamimi N et al - Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs. World J Nephrol 2014;3:156-168.

  • 15. White WB - Ambulatory blood-pressure monitoring in clinical practice. N Engl J Med 2003;348:2377–2378.

  • 16. Mancia G Fagard R Narkiewicz K et al - 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). .J Hypertens 2013;31:1281-357.

  • 17. Burnier M Pruijm M Wuerzner G Santschi V - Drug adherence in chronic kidney diseases and dialysis. Nephrol Dial Transplant 2015;30:39-44.

  • 18. David VG Yadav B Jeyaseelan L Deborah MN et al - Prospective blood pressure measurement in renal transplant recipients. Indian J Nephrol 2014;24:154-160.

  • 19. Ahmed J Ozorio V Farrant M Van Der Merwe W - Ambulatory vs Office Blood Pressure Monitoring in Renal Transplant Recipients. J Clin Hypertens (Greenwich) 2014; doi: 10.1111/jch.12448.

  • 20. Campistol JM Romero R Paul J Gutiérrez-Dalmau A - Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade. Nephrol Dial Transplant 2004;19(suppl 3):iii62-iii66.

  • 21. Castillo-Lugo JA Vergne-Marini P - Hypertension in kidney transplantation. Semin Nephrol 2005;25:252-260.

  • 22. Barbari A. - Posttransplant hypertension: multipathogenic disease process. Exp Clin Transplant 2013;11:99-108.

Journal information
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 677 293 142
PDF Downloads 622 259 149